The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse (pfgp)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03056586 |
Recruitment Status : Unknown
Verified March 2017 by Klein zvi, Meir Medical Center.
Recruitment status was: Not yet recruiting
First Posted : February 17, 2017
Last Update Posted : March 7, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Genital prolapse is a common complain. 30-40% of women will complain of uterine prolapse or cystocele or rectocele, or mixed. About half of them will require surgical repair for the prolapse, with or without hysterectomy. Of these patients about 30-40% will have recurrence of the prolapse, which in some cases requires second operation.
In this study the investigators want to investigate whether a vaginal pessary inserting in the end of the primary surgery, for 4 weeks, will reduce the recurrence rate.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Use of Pessary Reduce the Number of Prolapse Recurrence Uterine Prolapse Cystocele Rectocele | Device: vaginal pessary | Not Applicable |
All patients going for vaginal surgery for genital prolapse, stage 3-4, with cystocele, rectocele or uterine cervix prominent from the vagina. These patients, after signing an informed consent, a vaginal pessary will insert at the end of the operation and will stay for 4 weeks post-op.
After 4 weeks the pessary will be removed, and the patient will followed for 2 years, for recurrence of prolapse.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Prevention |
Official Title: | The Recurrence Rate of Genital Prolapse Post Repair With the Use of PESSARY for One Month Post Operative |
Estimated Study Start Date : | March 20, 2017 |
Estimated Primary Completion Date : | December 20, 2018 |
Estimated Study Completion Date : | December 20, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: 1. study group
100 patients who agree to participate in the study, will be operate according to our protocol for pelvic organ prolapse. At the end of the operation a vaginal pessary will be inserted and suture to the vaginal walls for a 4 week period. Follow-up will be after 3, 6, and 12 month period. |
Device: vaginal pessary
A vaginal pessary will be inserted at the end of the operation, for genital prolapse, and will be sutured to the vaginal wall. The pessary will stay in the vagina for 4 weeks. |
No Intervention: 2. control
100 Women who will refuse to participate in the study, will agree to be follow-up by our team for 3, 6, and 12 month post operative.
|
- Reduction of recurrence rate of vaginal prolapse, post vaginal surgery repair. [ Time Frame: 24 month ]The investigators hope to see a low percentage of prolapse recurrence in the study (pessary) group, comparing to the control (no pessary) group

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | women |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- all healthy patients with genital prolapse grade 3-4, going for vaginal surgery
- age 30-80years
Exclusion Criteria:
- patients with pelvic inflammatory disease
- patients after pelvic irradiation
- large vaginal erosion
- vaginal bleeding uncontrolled or undiagnosed
- patients going for surgery with mesh
Responsible Party: | Klein zvi, Head of urogynecology unit, Meir Medical Center |
ClinicalTrials.gov Identifier: | NCT03056586 |
Other Study ID Numbers: |
0188-16-MMC |
First Posted: | February 17, 2017 Key Record Dates |
Last Update Posted: | March 7, 2017 |
Last Verified: | March 2017 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Rectocele Cystocele Uterine Prolapse Recurrence Prolapse Disease Attributes Pathologic Processes Pathological Conditions, Anatomical Urinary Bladder Diseases |
Urologic Diseases Pelvic Organ Prolapse Uterine Diseases Rectal Diseases Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases Hernia |